Huang, a man whose mind operates on a plane where differential equations dance with tea leaves, does not merely “understand” artificial intelligence. He communes with it, as one might commune with a particularly argumentative ghost in a steam-powered calculating engine.²
Out of Vancouver, this outfit has been making waves, the kind you notice on the stock market. The price shot up like a rocket in 2025—430%, to be precise, up to July 31. Investors, those hopeful souls, have lined up like moths to a flame, thinking that the future of clean energy lies under the sea. The Metals Company wants to scoop up these nodules—polymetallic, fancy name for lumps of metal, heavy with nickel, copper, cobalt, and manganese. All essential to the electric vehicle revolution, or so they say. But the truth’s always got a funny way of surfacing, doesn’t it?
As of today, our little Floki friend is trading at $0.00010620, which is a bit like finding a shiny penny in your pocket after a long, hard day. It’s not much, but it’s something, right?
The difficulty, that most fickle of metrics, shall descend by a mere 3%, a paltry 123.7 trillion, as the block time, that steadfast sentinel of 10 minutes and 20 seconds, remains a beacon of constancy in this ever-shifting landscape. 🕒💸
Though our dear ONDO has been thrust into a corrective lull, the chart whispers sweet nothings about an enduring bullish spirit. Currently, it’s delicately testing a confluence zone—like an elegant flâneur pausing at a café before striding blithely into the sunrise of a possible ascent. ☕✨
But rich stories come with high valuations, like clothes with too many zippers—impressive on the outside but suspiciously confounding underneath. Palantir’s P/E ratio is nearing 700, which, if you’re not into math, means analysts are basically betting on this company being a miracle machine, or just that they really, really believe in AI’s future. The forward P/E is still sitting at 270, just to keep the thrill alive. Investors are riding a roller coaster with no brakes, clinging to the hope that Palantir’s AI will reinvent everything from warfare to warehouse management—because who doesn’t want their next conspiracy theory to come with a profit margin?
QuantumScape’s breakthrough? A production process 25 times faster. Not a tweak. A gut punch to the old ways. The kind of edge that makes engineers whisper, “Now we might just make it.” But hope’s a fickle currency. The euphoria’s half-unraveled already. Investors remembered what they forgot: prototypes don’t pay bills. Not yet. Still, this pullback? A door left ajar. A second chance for the bold.
The group’s message, urgent yet ironic, asks the esteemed lawmakers to draft a cyber-law that won’t make developers feel like they’re walking on a plotting minefield. A plea for tech neutrality — because who doesn’t want a bill that treats crypto like a chameleon, not a broomstick? 🦎🧹
Confession: I have a thing for moats. Economic moats, not the crocodile kind (though honestly, both are equally compelling from an investing standpoint). And Intuitive Surgical (ISRG)? They’re the castle, the moat, and probably the village idiot who’s trying to work out how to swim across.
They’ve been selling the da Vinci system since the late 90s—back before robots in the medical field were more than sci-fi fodder and everyone still thought Clippy was helpful. Now, they’re in bladder, womb, abdominal cavity, and sometimes the hearts of patients who probably didn’t expect to meet a robot on the way to the hospital.
Intuitive doesn’t just sell hardware; no, that would be too basic. They play the classic “razor-and-blades” game. Buy the dazzling system (the “razor”), then spend eternity buying its accessories (the “blades”), which, frankly, should come with a warning: “Side effects may include recurring revenue and mild feelings of helpless addiction.” Even their service contracts are irresistible. As a trader, I see “recurring revenue” and my heart flutters—because consistency, however illusory, is sexier than spontaneity in this business.
Their Q2? $2.4 billion up 21%—not bad for a company that already dominates its niche. Instruments and accessories are the real cash cows ($1.47 billion), with the systems and services content to play supporting roles. Ten thousand da Vinci systems installed worldwide—tell me they’re not setting up world domination in the least villainous way possible.
[stock_chart symbol="NASDAQ:ISRG" f_id="204057" language="en"]Still, if you’re anxious about buying in right now, what with a price-to-earnings ratio hovering at 70—well, welcome to the club. I lose sleep over valuation, too. But surgical robots aren’t exactly household appliances yet, so there’s runway. Would I buy at this price? Perhaps with one eye open and the other on the “Sell” button, but five years is a long time, and history’s on their side (119% earnings growth over five years is enough to make my therapist nod encouragingly).
At roughly $118,000, Bitcoin stands at a crossroads, where fresh liquidity and a faltering dollar might converge into a gale. To the value investor, this is no mere speculation but a test of patience, a moment where history whispers of opportunity to those who listen.
